Clinical and translational cancer research
The goal of the T32 Vanderbilt Integrated Molecular Oncology Research Training Program (VIMORTP) is to provide individuals with the training, mentorship, and collaborative interactions necessary for them to have successful and independent careers in clinical and translational cancer research.
Specific aims of the program:
- To recruit, support, and develop top-tier junior physician-scientists and clinician-investigators with a strategic translational focus into cancer research
- To provide a unique and outstanding translational research training experience with opportunities to develop sufficient knowledge, skills, and expertise to successfully pursue independent investigative careers concentrated on clinical molecular oncology with a focus on training that exploits bench-to-bedside and bedside-to-bench paradigms
- To develop skills that support this career, including communication, resiliency, team building, collaborative science, and grant writing/grant management
- To prioritize the recruitment of women and underrepresented minority trainees into clinical and molecular translation in oncology and support all aspects of career development necessary for a sustained and highly rewarding career.